Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting

被引:7
|
作者
Dong, Olivia M.
Wiltshire, Tim
机构
[1] Univ North Carolina Chapel Hill, Div Pharmacotherapy & Expt Therapeut, UNC Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ North Carolina Chapel Hill, Ctr Pharmacogen & Individualized Therapy, Chapel Hill, NC USA
关键词
precision medicine; pharmacogenetics; preemptive genotyping; CONSORTIUM CPIC GUIDELINES; UNIVERSITY-OF-FLORIDA; PERSONALIZED MEDICINE; 2014; UPDATE; PATIENTS PROJECT; GENOTYPE; PROGRAM; DESIGN; THERAPY; TIME;
D O I
10.1152/physiolgenomics.00029.2017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The incorporation of precision medicine into the clinical setting is becoming increasingly feasible with the availability of more affordable genetic sequencing technologies and successful genetic associations with phenotypes, especially in the pharmacogenomic field. Although substantial progress has been made to ensure successful uptake of pharmacogenomic testing in the clinical setting already, many challenges still remain for sustainable implementation. The importance of pharmacogenomic information in patient care, identifying key barriers, and proposed solutions for advancing pharmacogenomic implementation will be discussed.
引用
收藏
页码:346 / 354
页数:9
相关论文
共 50 条
  • [1] Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing
    Ikediobi, O. N.
    Shin, J.
    Nussbaum, R. L.
    Phillips, K. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 28 - 31
  • [2] Challenges in the clinical implementation of precision medicine companion diagnostics
    Keeling, Peter
    Clark, Jordan
    Finucane, Stephanie
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (06) : 593 - 599
  • [3] Pharmacogenetic testing in the UK clinical setting
    Bartlett, Mark J.
    Green, David W.
    Shephard, Elizabeth A.
    LANCET, 2013, 381 (9881): : 1903 - 1903
  • [4] Implementation of pharmacogenetic testing in medication reviews in a hospital setting
    Hjemas, Bodil Jahren
    Bovre, Katrine
    Bjerknes, Kathrin
    Mathiesen, Liv
    Mellingsaeter, Marte Christine Rognstad
    Molden, Espen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 3116 - 3125
  • [5] Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt
    Nagy, Mohamed
    Lynch, Meghan
    Kamal, Sherif
    Mohamed, Sarah
    Hadad, Alaa
    Abouelnaga, Sherif
    Aquilante, Christina L.
    PERSONALIZED MEDICINE, 2020, 17 (04) : 251 - 260
  • [6] Just how feasible is pharmacogenetic testing in the primary healthcare setting?
    Swen, Jesse J.
    Guchelaar, Henk-Jan
    PHARMACOGENOMICS, 2012, 13 (05) : 507 - 509
  • [7] Challenges of development and implementation of point of care pharmacogenetic testing
    Haga, Susanne B.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (09) : 949 - 960
  • [8] Implementation of pharmacogenomics testing for precision medicine
    Kanegusuku, Anastasia L. Gant
    Chan, Clarence W.
    O'Donnell, Peter H.
    Yeo, Kiang-Teck J.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (02) : 89 - 106
  • [9] CONTRIBUTION OF THE CYP2C9 PHARMACOGENETIC ANALYSIS TO THE IMPLEMENTATION OF PRECISION MEDICINE IN THE CLINICAL PRACTICE
    Marcos-Vadillo, E.
    Garcia-Berrocal, B.
    Martin, C. P.
    Sanchez-Martin, A.
    Sanchez-Iglesias, S.
    Lorenzo, C.
    Franco, M.
    Isidoro-Garcia, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 85 - 85
  • [10] Bridging the Gap: Advancing Pharmacogenetic Testing Through Comprehensive Implementation and Evaluation Strategies
    Rogers, Sara
    Silva, Patrick J.
    Ramos, Kenneth
    THERAPEUTIC DRUG MONITORING, 2025, 47 (02) : 185 - 188